Dean Capital Management Grows Stake in Maximus, Inc. $MMS

Dean Capital Management increased its holdings in Maximus, Inc. (NYSE:MMS) by 57.5% during the third quarter, Holdings Channel reports. The firm owned 38,183 shares of the health services provider’s stock after acquiring an additional 13,941 shares during the quarter. Maximus makes up 1.4% of Dean Capital Management’s portfolio, making the stock its 11th biggest holding. Dean Capital Management’s holdings in Maximus were worth $3,489,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in MMS. Arizona State Retirement System grew its holdings in Maximus by 0.9% during the 3rd quarter. Arizona State Retirement System now owns 16,674 shares of the health services provider’s stock valued at $1,524,000 after buying an additional 156 shares in the last quarter. GAMMA Investing LLC lifted its holdings in shares of Maximus by 13.9% in the third quarter. GAMMA Investing LLC now owns 1,337 shares of the health services provider’s stock worth $122,000 after buying an additional 163 shares in the last quarter. Trust Point Inc. lifted its holdings in shares of Maximus by 3.7% in the third quarter. Trust Point Inc. now owns 5,286 shares of the health services provider’s stock worth $483,000 after buying an additional 191 shares in the last quarter. Richardson Financial Services Inc. boosted its position in shares of Maximus by 123.1% during the third quarter. Richardson Financial Services Inc. now owns 348 shares of the health services provider’s stock worth $32,000 after acquiring an additional 192 shares during the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Maximus by 0.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 34,476 shares of the health services provider’s stock worth $2,351,000 after acquiring an additional 221 shares during the last quarter. 97.21% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on MMS shares. Wall Street Zen downgraded shares of Maximus from a “buy” rating to a “hold” rating in a report on Monday, February 23rd. Zacks Research raised shares of Maximus from a “hold” rating to a “strong-buy” rating in a report on Tuesday, December 30th. Finally, Weiss Ratings cut Maximus from a “buy (b)” rating to a “hold (c+)” rating in a report on Tuesday, February 24th. One research analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat, Maximus has a consensus rating of “Buy”.

Insider Transactions at Maximus

In related news, CFO David Mutryn purchased 1,000 shares of the company’s stock in a transaction that occurred on Monday, February 9th. The stock was bought at an average price of $75.62 per share, for a total transaction of $75,620.00. Following the completion of the transaction, the chief financial officer owned 40,037 shares in the company, valued at approximately $3,027,597.94. The trade was a 2.56% increase in their position. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Bruce Caswell purchased 3,175 shares of the company’s stock in a transaction that occurred on Tuesday, February 10th. The stock was bought at an average price of $78.45 per share, with a total value of $249,078.75. Following the transaction, the chief executive officer owned 328,013 shares of the company’s stock, valued at $25,732,619.85. This represents a 0.98% increase in their position. The SEC filing for this purchase provides additional information. Insiders own 1.80% of the company’s stock.

Maximus Stock Down 0.0%

NYSE MMS opened at $72.40 on Monday. The company has a debt-to-equity ratio of 0.88, a quick ratio of 2.34 and a current ratio of 2.34. The company has a market capitalization of $3.95 billion, a P/E ratio of 11.02 and a beta of 0.59. Maximus, Inc. has a one year low of $64.68 and a one year high of $100.00. The stock has a 50 day moving average price of $84.50 and a 200-day moving average price of $85.67.

Maximus (NYSE:MMS) last posted its earnings results on Thursday, February 5th. The health services provider reported $1.85 earnings per share for the quarter, beating analysts’ consensus estimates of $1.84 by $0.01. The firm had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.37 billion. Maximus had a net margin of 6.92% and a return on equity of 25.30%. Maximus’s revenue for the quarter was down 4.1% compared to the same quarter last year. During the same period last year, the firm posted $1.61 earnings per share. Maximus has set its FY 2026 guidance at 8.050-8.350 EPS. As a group, equities analysts predict that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, March 2nd. Stockholders of record on Friday, February 13th were issued a $0.33 dividend. This is a boost from Maximus’s previous quarterly dividend of $0.30. The ex-dividend date was Friday, February 13th. This represents a $1.32 dividend on an annualized basis and a dividend yield of 1.8%. Maximus’s payout ratio is presently 20.09%.

Maximus Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.